Summary
The in vitro effect of pirprofen (Rengasil), an antiinflammatory agent, on the surface ultrastructure and function of human platelets was examined and compared with that of acetylsalicylic acid (Aspirin, ASA), and diclofenac sodium (Voltaren, DS). Incubation with pirprofen induced formation of long, neddle-shaped pseudopodia, a phenomenon observed also after incubation of the cells with DS. In contrast with ASA and DS, pirprofen induced a marked increase in platelet protein synthesizing capacity. The drug decreased the platelet aggregation to a degree similar to that of ASA and DS. The release of platelet factors 3 and 4 and the level of β-thromboglobulin following incubation with the drug remained unaltered.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ancill RJ (1984) Pirprofen — a review. Drugs Today 20: 121–130
Bessler H, Agam G, Djaldetti M (1976) Increased protein synthesis by human platelets during phagocytosis of latex particles in vitro. Thromb Haemostas 35: 350–357
Born GVR, Cross MJ (1963) The aggregation of blood platelets. J Physiol (Lond) 168: 178–195
Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 97 (Suppl 21): 77–97
Djaldetti M, Bessler H, Fishman P (1978) Drug-induced platelet surface alterations. A possible mechanism for impaired aggregation. Haematologica 63: 531–547
Djaldetti M, Fishman P, Creter D, Notti I (1982) Ultrastructural and functional studies on human platelets incubated with diclofenac-sodium (Voltaren). Acta Haematol 68: 285–294
Djaldetti M, Fishman P, Cohen A, Roffman E, Levinsky H, Glaser M, Zahavi I (1983) Effect of diclofenac-sodium (Voltaren) on the electrical charge of human platelet membrane. Acta Haematol 70: 296–301
Doery JCG, Hirsh J (1971) Divergent effects of aspirin and salicylate on glucose and glycogen metabolism in human platelets. Experientia 27: 533–534
Hardisty RM, Hutton RA (1965) The kaolin clotting time of platelet-rich plasma: a test of platelet factor-3 availability. Br J Haematol 11: 258–268
Smith JB, Willis AL (1971) Aspirin selectively inhibits prostaglandin production in human platelets. Nature (New Biol) 231: 235–237
Todd PA, Beresford R (1986) Pirprofen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 32: 509–537
Tsurumi K, Mibu H, Hasegawa J, Fujimura H (1983) Effect of pirprofen on leucocyte migration and platelet aggregation. Oyo Yakuri (Pharmacometrics) 25: 331–337
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) 231: 232–235
Vane JR (1974) Mode of action of aspirin and similar compounds. In: Robinson and Vane (eds) Prostaglandin synthetase inhibitors. Raven Press, New York, pp 155–163
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Djaldetti, M., Gilgal, R., Creter, D. et al. The in vitro effect of pirprofen on the surface ultrastructure and function of human platelets. Blut 56, 165–169 (1988). https://doi.org/10.1007/BF00320747
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320747